HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The results of combined treatment (surgery and postoperative radiotherapy) for tongue cancer and prognostic factors].

AbstractOBJECTIVES:
We evaluated the results of surgical treatment and postoperative radiotherapy and prognostic factors in patients with primary tongue carcinoma.
PATIENTS AND METHODS:
The study included 60 patients (31 males, 29 females; median age 54 years; range 22 to 82 years) who underwent surgery and postoperative radiotherapy for oral tongue cancer. Tumor staging based on the AJCC-1997 criteria was as follows: stage I (n=1), stage II (n=21), stage III (n=12), and stage IVA (n=26). Surgery included hemiglossectomy (n=46, 76%), partial (n=13, 22%) and total (n=1, 2%) glossectomy. Neck dissection was performed in 47 patients (78%). Radiotherapy dose was generally 6000 cGy/30 fr. The median follow-up was 51 months (range 5 to 180 months).
RESULTS:
The five-year overall and relapse-free survival rates were 50% and 47%, respectively. Survival at five years was 70% for stage I-III, and 20% for stage IVA. Most of the relapses occurred in the first two years after treatment. Recurrences were encountered in 31 patients (52%). The median survival after recurrence was eight months (range 1 to 53 months). In multivariate analyses, significant prognostic factors for overall survival and locoregional control were tumor size, stage, N stage, extracapsular lymph node spread, and total duration of radiotherapy. Complications were within acceptable limits.
CONCLUSION:
Postoperative radiotherapy should be standard for patients with stage III and IVA tongue cancer.
AuthorsAhmet Karadeniz, Mert Saynak, Züleyha Kadehci, Merdan Fayda, Görkem Aksu, Hümeyra Kocaelli, Günter Hafiz
JournalKulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat (Kulak Burun Bogaz Ihtis Derg) Vol. 17 Issue 1 Pg. 1-6 ( 2007) ISSN: 1300-7475 [Print] Turkey
Vernacular TitleDil kanserinde kombine tedavi (cerrahi ve radyoterapi) sonuçlari ve prognostik faktörler.
PMID17483603 (Publication Type: Evaluation Study, Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell (mortality, pathology, radiotherapy, surgery)
  • Combined Modality Therapy
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (mortality, pathology, radiotherapy, surgery)
  • Neoplasm Staging
  • Survival Analysis
  • Tongue Neoplasms (mortality, pathology, radiotherapy, surgery)
  • Treatment Outcome
  • Turkey (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: